CASTLE BIOSCIENCES, INC. Temporary Equity, Dividends, Adjustment
CASTLE BIOSCIENCES, INC. (CSTL) reported Temporary Equity, Dividends, Adjustment of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:TemporaryEquityDividendsAdjustment · last filed 2021-03-11
- CASTLE BIOSCIENCES, INC. temporary equity, dividends, adjustment for the quarter ending 2020-12-31 was $0.00.
- CASTLE BIOSCIENCES, INC. temporary equity, dividends, adjustment for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- CASTLE BIOSCIENCES, INC. temporary equity, dividends, adjustment for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- CASTLE BIOSCIENCES, INC. temporary equity, dividends, adjustment for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- CASTLE BIOSCIENCES, INC. temporary equity, dividends, adjustment for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- CASTLE BIOSCIENCES, INC. temporary equity, dividends, adjustment for fiscal 2019 was $2.16M, a 39.73% decline from fiscal 2018.
- CASTLE BIOSCIENCES, INC. temporary equity, dividends, adjustment for fiscal 2018 was $3.58M.
| Period end | Temporary Equity, Dividends, Adjustment 3 month | Temporary Equity, Dividends, Adjustment 3 month as first filed | Temporary Equity, Dividends, Adjustment 6 month | Temporary Equity, Dividends, Adjustment 6 month as first filed | Temporary Equity, Dividends, Adjustment 9 month | Temporary Equity, Dividends, Adjustment 9 month as first filed | Temporary Equity, Dividends, Adjustment 12 month |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-11 | $0.00 derived: sum of 3 quarters · filed 2021-03-11 | $0.00 10-K · filed 2021-03-11 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 4 quarters · filed 2021-03-11 | |||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | $0.00 derived: sum of 3 quarters · filed 2021-03-11 | $289.00K derived: sum of 4 quarters · filed 2021-03-11 | |||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-11 | $289.00K derived: sum of 3 quarters · filed 2021-03-11 | $1.23M derived: sum of 4 quarters · filed 2021-03-11 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $289.00K derived: sum of 2 quarters · filed 2021-03-11 | $1.23M derived: sum of 3 quarters · filed 2021-03-11 | $2.16M 10-K · filed 2021-03-11 | |||
| 2019-09-30 | $289.00K 10-Q · filed 2020-11-09 | $288.89K 10-Q · filed 2019-11-12 | $1.23M derived: sum of 2 quarters · filed 2020-11-09 | $2.16M 10-Q · filed 2020-11-09 | $2.16M 10-Q · filed 2019-11-12 | $3.11M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $939.00K 10-Q · filed 2020-08-10 | $938.89K 10-Q · filed 2019-09-03 | $1.87M 10-Q · filed 2020-08-10 | $1.87M 10-Q · filed 2019-09-03 | $2.82M derived: sum of 3 quarters · filed 2020-08-10 | $3.77M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | $928.00K 10-Q · filed 2020-05-11 | $1.88M derived: sum of 2 quarters · filed 2020-05-11 | $2.83M derived: sum of 3 quarters · filed 2020-05-11 | $3.70M derived: sum of 4 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $949.47K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $1.90M derived: sum of 2 quarters · filed 2020-03-10 | $2.77M derived: sum of 3 quarters · filed 2020-03-10 | $3.58M 10-K · filed 2020-03-10 | |||
| 2018-09-30 | $949.20K 10-Q · filed 2019-11-12 | $1.82M derived: sum of 2 quarters · filed 2019-11-12 | $2.63M 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $869.01K 10-Q · filed 2019-09-03 | $1.68M 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |